… and therapy for patients with COVID-19 are necessary. … in ICU patients than non-ICU patients
hospitalized with COVID-19 [… ICU than in non-ICU patients hospitalized with COVID-19 [10]. …

… of COVID-19 patients. Interferons (IFNs) have shown to be crucial in fighting with COVID-19 …
available information about SARS-CoV-2 and probable therapies for COVID-19 patients. …

… rates as high as 63% in patients without COVID-19. Granular, nationally representative
data on AKI-RRT in patients with COVID-19 are urgently needed to inform clinical decision …

… Extracorporeal treatments do not compromise the experimental antibody-based therapies
used in COVID-19, such as tocilizumab, intravenous immunoglobulins, and convalescent …

… Recently, a meta-analysis was performed to assay the efficacy of IVIG therapy for COVID-19
patients [100]. In this meta-analysis, four clinical trials and three cohort studies containing …

… used in treating coronavirus disease 2019 (COVID-19) patients. … cohort study of 446
COVID-19 patients in Hubei, China. … of COVID-19 could induce favorable clinical responses. …

… [1, 2] Most COVID-19 patients will develop mild to moderate … is no specific antiviral therapy
for COVID-19, understanding of … different cytokine profiles in patients with severe COVID-19.[1, …

… This study showed CP therapy was welltolerated and could potentially improve the clinical …
COVID-19 cases. The optimal dose and time point, as well as the clinical benefit of CP therapy…

… ) on a background of interferon alpha therapy in patients from China with milder COVID-19
without hypoxemia or respiratory distress and demonstrated earlier viral clearance in those …

… Based on current evidence, recent guidelines of the National Institute of Health, USA indicated
the use of remdesivir and dexamethasone for the treatment of COVID-19 patients with mild…